Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent Prostate Cancer”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableNot Yet RecruitingNCT06875297
What this trial is testing

A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 184
Testing effectiveness (Phase 2)Study completedNCT00148772
What this trial is testing

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Who this might be right for
Prostate Cancer
Endeavor Health 29
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Not applicableStudy completedNCT06204302
What this trial is testing

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Who this might be right for
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Bayer 1,800
Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Testing effectiveness (Phase 2)Looking for participantsNCT07365423
What this trial is testing

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Who this might be right for
Recurrent Prostate Cancer
Swiss Cancer Institute 42
Large-scale testing (Phase 3)Study completedNCT00838201
What this trial is testing

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Who this might be right for
CancerCarcinomaCastrate-Resistant Prostate Cancer+2 more
Amgen 384
Early research (Phase 1)Study completedNCT00629057
What this trial is testing

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Androgen-insensitive Prostate Cancer
Bavarian Nordic 24
Testing effectiveness (Phase 2)Looking for participantsNCT07073794
What this trial is testing

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Large-scale testing (Phase 3)Looking for participantsNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Study completedNCT05526248
What this trial is testing

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 28
Not applicableStudy completedNCT01118741
What this trial is testing

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Not applicableEnded earlyNCT05437679
What this trial is testing

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Who this might be right for
High Risk Prostate CarcinomaBiochemically Recurrent Prostate CarcinomaCastration-resistant Prostate Cancer+1 more
Angle plc 9
Testing effectiveness (Phase 2)Looking for participantsNCT06220188
What this trial is testing

PSMA-RLT in Biochemically Recurrent PCa

Who this might be right for
Prostate Cancer Recurrent
Medical University of Vienna 20
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009967
What this trial is testing

Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Load More Results